Skip to content

Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients

Association of Hyperuricemia and Non Alcoholic Fatty Liver Disease and Liver Fibrosis Risk in Adult Obese Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07168551
Enrollment
111
Registered
2025-09-11
Start date
2025-10-01
Completion date
2026-12-01
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia, Liver Fibrosis, NAFLD (Nonalcoholic Fatty Liver Disease)

Brief summary

1. Identifying the association between hyperuricemia and NAFLD can lead to early detection and prevention of liver fibrosis in adult obese patients. 2. Understanding the relationship between hyperuricemia and NAFLD can inform targeted therapy, such as urate-lowering treatment, to potentially slow disease progression. 3 - To examine the relationship between serum uric acid levels and liver fibrosis severity\*: Assessing the correlation between serum uric acid levels and the severity of liver fibrosis in adult obese patients with NAFLD. 4- To identify potential mechanisms underlying the association\*: Exploring the potential mechanisms by which hyperuricemia may contribute to the development and progression of NAFLD and liver fibrosis in adult obese patients.

Detailed description

Hyperuricemia is associated with nonalcoholic fatty liver disease (NAFLD), whereas whether the association differed by hyperuricemia onset age remained unclear. This study sought to investigate the associations of hyperuricemia onset age with the risk of incident NAFLD across adulthood. Obesity has been demonstrated to show a consistent link with the increased possibility of nonalcoholic fatty liver disease (NAFLD). Since both serum uric acid (SUA) and obesity are essential components of metabolic syndrome (MetS), it is uncertain whether the incidence of NAFLD results from serum uric acid, obesity, or other potential factors based on previous studies.

Interventions

DIAGNOSTIC_TEST*Lab Methods:* 1- Serum Uric Acid levels 2-Liver Function Tests 3- Lipid Profile . 4- Haemoglobin A1c level . 5- Serum glucose level .

Lab methods

RADIATION*Imaging Studies:* 1- Ultrasound 2 - FibroScan

Imaging

DEVICEInstruments:* 1- *Automated Analyzers*: Used for blood tests, such as serum uric acid and liver function tests.

Instrument

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age: Adults (typically 18-65 years old) 2 - Body Mass Index (BMI): Obese patients with a BMI ≥ 30 kg/m² 3- Hyperuricemia : Elevated serum uric acid levels (typically \> 7 mg/dL for men and \> 6 mg/dL for women)

Exclusion criteria

* excessive alcohol consumption ( \> 20 gm /day in men and 10 in g /day in women ) 2- use of steatogenic within the past 6 months 3- positive test for hepatitis B surface antigen and hepatitis B core antibody 4- Drug induced liver injury and autoimmune hepatitis 5 - cirrhosis and other causes of liver disease

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of NAFLD1 yearThe proportion of adult obese patients with NAFLD in the study population

Secondary

MeasureTime frameDescription
Serum uric acid level1 yearThe serum uric acid level in adult obese patients

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026